Symposium on Precision Medicine in Cancer Treatment
The Capital Region Cancer Research (CRCR) group will host a symposium on precision medicine in cancer treatment and prevention on Friday, June 11, from 9 a.m. to 2:30 p.m. This virtual event, designed for those who work on various aspects of cancer research, is free to attend but registration is required.
“Precision medicine is transforming the medical treatment landscape, including cancer care,” said Dana Crawford, PhD, associate professor in the Department of Immunology and Microbial Disease at Albany Medical College and chair of the CRCR. “Theranostics, cytokine-directed therapy, Fluorescent Lifetime FRET imaging, single-cell transcriptomic profiling and other new strategies promise to play a major role in contributing to the ultimate goal of the CRCR – the cure of cancer.”
Presenters include experts from local organizations, as well as from MD Anderson Cancer Center and the National Cancer Institute.
The symposium’s first session, chaired by Dong-Joo (Ellen) Cheon, PhD, assistant professor in the Department of Regenerative and Cancer Cell Biology at Albany Medical College, will focus on basic studies, challenges and innovation in cancer-related precision medicine.
The program will also feature discussions on the impact of research on breast cancer patients and survivors, and the importance of community-based cancer patient organizations. The event will conclude with presentations on precision medicine in patient-based cancer studies.
The CRCR promotes cancer research interactions among Albany-area facilities and personnel. Member organizations include Wadsworth Center, State University of New York at Albany, Albany Med, General Electric, Rensselaer Polytechnic Institute, SUNY Polytechnic Institute, Albany College of Pharmacy and Health Sciences, Stratton VA Medical Center, Taconic Biosciences, Inc. and New York Oncology Hematology.